
Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Description
Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Endocrinology Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Endocrinology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Endocrinology Tests are the reagents used for quantification and detection of endocrine hormones secreted in the human body.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Endocrinology Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Endocrinology Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Endocrinology Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
100 Pages
- About GlobalData
- Endocrinology Tests Overview
- Endocrinology Tests - Pipeline Products by Stage of Development
- Endocrinology Tests - Pipeline Products by Segment
- Endocrinology Tests - Pipeline Products by Territory
- Endocrinology Tests - Pipeline Products by Regulatory Path
- Endocrinology Tests - Pipeline Products by Estimated Approval Date
- Endocrinology Tests Companies - Pipeline Products by Stage of Development
- Endocrinology Tests – Companies Pipeline Products by Stage of Development
- Albert Einstein College of Medicine Company Overview
- AMS Diagnostics LLC Company Overview
- Axis-Shield Diagnostics Ltd Company Overview
- Beckman Coulter Inc Company Overview
- Carolina Liquid Chemistries Corp Company Overview
- Celmatix Inc Company Overview
- Ceres Nanosciences Inc Company Overview
- Columbia University Company Overview
- Denka Seiken Co Ltd Company Overview
- DIANA Biotechnologies SRO Company Overview
- DiaSorin SpA Company Overview
- EDP Biotech Corporation Company Overview
- G Medical Health and Wellness Company Overview
- Guangzhou Wondfo Biotech Co Ltd Company Overview
- Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview
- I-Mab Biopharma Co Ltd Company Overview
- Intelligent Bio Solutions Inc Company Overview
- Laboratoire HRA Pharma SAS Company Overview
- MDNA Life Sciences Inc Company Overview
- MyHealthTest Pty Ltd Company Overview
- Revvity Inc Company Overview
- Roche Diagnostics International Ltd Company Overview
- Sendera Discovery Company Overview
- Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview
- Siemens Healthcare Diagnostics Inc Company Overview
- Solvd Health Company Overview
- Thermo Fisher Scientific Inc Company Overview
- Tosoh Bioscience Inc Company Overview
- University of California San Francisco Company Overview
- Aug 31, 2023: Integrated Diagnostics Holdings Announces Half Year Report
- Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1
- Jun 07, 2023: Eckert & Ziegler Strahlen Annual General Meeting Approves Dividend of EUR 0.50 per Share
- Jun 01, 2023: Integrated Diagnostics announces Q1 2023 Results
- Apr 06, 2023: Integrated Diagnostics Holdings Announces Final Results
- Apr 06, 2023: Integrated Diagnostics Holdings concludes 2022 reporting solid 18% growth in non- Covid revenues
- Feb 22, 2023: Novo Nordisk Notice for the Annual General Meeting
- Dec 20, 2022: Eckert & Ziegler Announces Changes in the Supervisory Board
- Dec 19, 2022: Eckert & Ziegler Announces Changes in the Management Board
- Nov 17, 2022: Integrated Diagnostics Holdings 3rd Quarter Results
- Oct 31, 2022: IDH and its Jordanian subsidiary, Biolab, to Launch Greenfield Diagnostic Venture in Saudi Arabia in Partnership with Izhoor Medical, a company owned by Fawaz Alhokair
- Oct 05, 2022: DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.